National International Holding Company
Ticker/ISIN
NIH
KW0EQ0201677
Market/Country
Dubai Financial Market
United Arab Emirates
About National International Holding Company
Country of Origin: Kuwait
National International Holding Company (NIH) is Kuwaiti Shareholding Company established in State of Kuwait in 14/01/1979 under commercial license 27854. NIH was listed in Kuwait Stock Exchange in 11/01/2005.
The company adopting a specific and clear investment policy in various scopes in the domestic market of Kuwait and in the Gulf countries markets as well as European, Australian, and American markets, in various sectors, industrial, real estate, educational, technological, and investments
Latest Pressrelease Summaries from National International Holding Company
National International Holding Co. K.P.S.C. (NIH) informed Mr. Hamed Ahmed Ali, CEO of Dubai Financial Market, about the sale of treasury shares. The disclosure was made on 04/09/2024 by Mamdouh A. EL Sherbiny, CEO and Board Member of NIH. The company, established in 1979 with authorized and paid capital of 23,455,301 600 K.D, is located in Sharq, Kuwait.
National International Holding Co. K.P.S.C. (NIH) has informed Mr. Hamed Ahmed Ali, the CEO of Dubai Financial Market, that they have sold treasury shares. The details of the sale are included in an attached disclosure. The communication is signed by Mamdouh A. EL Sherbiny, CEO and Board Member of NIH. The company, established in 1979, is headquartered in Kuwait.
National International Holding Co. K.P.S.C. (NIH) has informed the Dubai Financial Market, through a letter dated 02/09/2024 addressed to its CEO, Mr. Hamed Ahmed Ali, that it has sold treasury shares. The disclosure details are attached to the letter. The communication is signed by Mamdouh A. EL Sherbiny, CEO and Board Member of NIH. The company, established in 1979, is based in Kuwait and has authorized and paid capital of 23,455,301.600 K.D.
National International Holding Company (NIH) has received approval from the Capital Markets Authority (CMA) to buy or sell up to 10% of its treasury shares. This approval is valid for six months starting from August 27, 2024, and is subject to the availability of financial resources, in accordance with Law no. 7 of 2010 and its subsequent amendments. The company states that this action will have no impact on its financial position. The letter was signed by Mamdouh A. EL Sherbiny, CEO and Board Member of NIH.
On 14th February 2024, the CEO of National International Holding Co. KPs.c, Mamdouh A. EL Sherbiny, communicated to the CEO of Dubai Financial Market, Mr. Hamed Ahmed Ali, the preliminary financial results for the company for the year ended 31st December 2023. The financial results were provided in both English and Arabic.
Threads
Page 1
Disclosure: Corrective Announcement: General Assembly Meeting
Disclosure: Commencement of the nomination period for BOD membership at NIH Company
Disclosure: Invitation of General Assembly
Disclosure: Corrective Disclosure - Changing the date of the invitation for AGM
Disclosure: Results of BOD Meeting
Disclosure: BOD meeting
Disclosure: Disclosure of Material Information
Disclosure: Results of BOD Meeting
Disclosure: Financial statements for the 3rd QTR of 2024
Disclosure: Disclosure of material information
Page 1